APPLICATION
ANDA076025
TYPE
ANDA
ORIGINAL APPROVAL
2003-03-31
LATEST ACTION
2012-02-06
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription
Products
IPRATROPIUM BROMIDEPrescription
IPRATROPIUM BROMIDE 0.021MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2012-02-06Labeling · Supplement 6AP
2007-12-20Labeling · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.